<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font14 { font-size : 14; } .font15 { font-size : 15; } .font16 { font-size : 16; } .font17 { font-size : 17; } .font18 { font-size : 18; } .font19 { font-size : 19; } .font20 { font-size : 20; } .font21 { font-size : 21; } .font23 { font-size : 23; } .font24 { font-size : 24; } .font26 { font-size : 26; } .font30 { font-size : 30; }</style>
 <body>
  <p>
   <span class="font30">mice </span>
   <span class="font26">YFV </span>
   <span class="font26">YFV-D </span>
   <span class="font26">virus </span>
   <span class="font24">JE-CVax </span>
   <span class="font23">cells </span>
   <span class="font21">vaccine </span>
   <span class="font20">protection </span>
   <span class="font19">PFU </span>
   <span class="font19">JEV </span>
   <span class="font19">cell </span>
   <span class="font18">fever </span>
   <span class="font17">serum </span>
   <span class="font17">yellow </span>
   <span class="font17">challenge </span>
   <span class="font16">vaccinated </span>
   <span class="font16">using </span>
   <span class="font16">(Fig. </span>
   <span class="font15">vaccination </span>
   <span class="font15">(). </span>
   <span class="font14">antibodies </span>
   <span class="font14">responses </span>
   <span class="font14">CBL/ </span>
   <span class="font14">infection </span>
   <span class="font14">assay </span>
   <span class="font14">chimeric </span>
   <span class="font14">flavivirus </span>
   <span class="font14">mice. </span>
   <span class="font14">Vero </span>
   <span class="font14">dengue </span>
   <span class="font14">lethal </span>
   <span class="font14">mouse </span>
   <span class="font14">performed </span>
   <span class="font14">JE-CVax-vaccinated </span>
   <span class="font14">analysis </span>
   <span class="font14">encephalitis </span>
   <span class="font13">Japanese </span>
   <span class="font13">antibody </span>
   <span class="font13">nonvaccinated </span>
   <span class="font13">used </span>
   <span class="font13">protective </span>
   <span class="font13">proteins </span>
   <span class="font13">{border-style </span>
   <span class="font13">Virol:–. </span>
   <span class="font13">animals </span>
   <span class="font13">immunity </span>
   <span class="font13">challenged </span>
   <span class="font13">human </span>
   <span class="font13">px;} </span>
   <span class="font13">#ffffff;} </span>
   <span class="font13">nAbs </span>
   <span class="font13">protein </span>
   <span class="font13">attenuated </span>
   <span class="font13">cellular </span>
   <span class="font13">data </span>
   <span class="font13">observed </span>
   <span class="font13">samples </span>
   <span class="font13">vaccines </span>
   <span class="font12">cells. </span>
   <span class="font12">determined </span>
   <span class="font12">neutralization </span>
   <span class="font12">(n = ) </span>
   <span class="font12">FIG </span>
   <span class="font12">IFN-γ </span>
   <span class="font12">SA-- </span>
   <span class="font12">binding </span>
   <span class="font12">different </span>
   <span class="font12">flow </span>
   <span class="font12">i.p. </span>
   <span class="font12">infected </span>
   <span class="font12">medium </span>
   <span class="font12">Mishra </span>
   <span class="font12">assays </span>
   <span class="font12">class </span>
   <span class="font12">day </span>
   <span class="font12">log </span>
   <span class="font12">titers </span>
   <span class="font12">(C) </span>
   <span class="font12">CPENT </span>
   <span class="font12">Ixiaro </span>
   <span class="font12">MHC </span>
   <span class="font12">TNF-α </span>
   <span class="font12">anti-mouse </span>
   <span class="font12">compared </span>
   <span class="font12">following </span>
   <span class="font12">live </span>
   <span class="font12">mice, </span>
   <span class="font12">Attribution </span>
   <span class="font12">Commons </span>
   <span class="font12">Creative </span>
   <span class="font12">Fig. </span>
   <span class="font12">International </span>
   <span class="font12">This </span>
   <span class="font12">YFV-D. </span>
   <span class="font12">distributed </span>
   <span class="font12">flaviviruses </span>
   <span class="font12">intracellular </span>
   <span class="font12">nonstructural </span>
   <span class="font12">peptide </span>
   <span class="font12">terms </span>
   <span class="font12">vivo </span>
   <span class="font11">(), </span>
   <span class="font11">./mBio.-.FIG </span>
   <span class="font11">Download </span>
   <span class="font11">JPG </span>
   <span class="font11">MB. </span>
   <span class="font11">YFV. </span>
   <span class="font11">content </span>
   <span class="font11">dose </span>
   <span class="font11">dpv </span>
   <span class="font11">dual </span>
   <span class="font11">file, </span>
   <span class="font11">hyperimmune </span>
   <span class="font11">immunization </span>
   <span class="font11">independent </span>
   <span class="font11">license. </span>
   <span class="font11">lysate </span>
   <span class="font11">splenocytes </span>
   <span class="font11">stained </span>
   <span class="font11">strain </span>
   <span class="font11">type </span>
   <span class="font11">use </span>
   <span class="font11">viral </span>
   <span class="font11">ADCC </span>
   <span class="font11">However, </span>
   <span class="font11">JE-CVax-mediated </span>
   <span class="font11">PRNT </span>
   <span class="font11">antigen </span>
   <span class="font11">immune </span>
   <span class="font11">means </span>
   <span class="font11">no. </span>
   <span class="font11">plates </span>
   <span class="font11">production </span>
   <span class="font11">weeks </span>
   <span class="font11"> days </span>
   <span class="font11">(A) </span>
   <span class="font11">Animals </span>
   <span class="font11">ELISpot </span>
   <span class="font11">YFV, </span>
   <span class="font11">YFV-specific </span>
   <span class="font11">activity </span>
   <span class="font11">available </span>
   <span class="font11">dilutions </span>
   <span class="font11">genes </span>
   <span class="font11">humans </span>
   <span class="font11">induces </span>
   <span class="font11">nAb </span>
   <span class="font11">negative </span>
   <span class="font11">neutralizing </span>
   <span class="font11">peptides </span>
   <span class="font11">prM/E </span>
   <span class="font11">prior </span>
   <span class="font11">px; </span>
   <span class="font11">recombinant </span>
   <span class="font11">replaced </span>
   <span class="font11">resulted </span>
   <span class="font11">sera </span>
   <span class="font11">standard </span>
   <span class="font11">subsequent </span>
   <span class="font11">survival </span>
   <span class="font11">test </span>
   <span class="font11">viruses </span>
   <span class="font11">{font-family </span>
   <span class="font11">BHK-J </span>
   <span class="font11">CPE </span>
   <span class="font11">DENV </span>
   <span class="font11">Fisher </span>
   <span class="font11">Gen </span>
   <span class="font11">HEK </span>
   <span class="font11">Imojev </span>
   <span class="font11">Vaccine:–. </span>
   <span class="font11">ZIKV </span>
   <span class="font11">absence </span>
   <span class="font11">anti-NS </span>
   <span class="font11">anti-YFV </span>
   <span class="font11">antibody-dependent </span>
   <span class="font11">background </span>
   <span class="font11">based </span>
   <span class="font11">challenge. </span>
   <span class="font11">considered </span>
   <span class="font11">cross-reactive </span>
   <span class="font11">cytometric </span>
   <span class="font11">described </span>
   <span class="font11">detected </span>
   <span class="font11">disease </span>
   <span class="font11">epitopes </span>
   <span class="font11">font-size </span>
   <span class="font11">humane </span>
   <span class="font11">humoral </span>
   <span class="font11">i.e., </span>
   <span class="font11">induce </span>
   <span class="font11">levels </span>
   <span class="font11">medium. </span>
   <span class="font11">non-nAbs </span>
   <span class="font11">noninfected </span>
   <span class="font11">presented </span>
   <span class="font11">previously </span>
   <span class="font11">replication </span>
   <span class="font11">respectively, </span>
   <span class="font11">shown </span>
   <span class="font11">similar </span>
   <span class="font11">single </span>
   <span class="font11">total </span>
   <span class="font11">uninfected </span>
   <span class="font11">virus. </span>
   <span class="font11"> ×  </span>
   <span class="font11"> μg/ml </span>
   <span class="font11">(B) </span>
   <span class="font11">-well </span>
   <span class="font11">C). </span>
   <span class="font11">Cells </span>
   <span class="font11">I-restricted </span>
   <span class="font11">Leuven </span>
   <span class="font11">Med:–. </span>
   <span class="font11">Moreover, </span>
   <span class="font11">Serum </span>
   <span class="font11">Statistical </span>
   <span class="font11">Thermo </span>
   <span class="font11">YFV-D-mCherry </span>
   <span class="font11">Zika </span>
   <span class="font11">and/or </span>
   <span class="font11">backbone </span>
   <span class="font11">case </span>
   <span class="font11">catalog </span>
   <span class="font11">challenge, </span>
   <span class="font11">clinical </span>
   <span class="font11">complete </span>
   <span class="font11">contribute </span>
   <span class="font11">control. </span>
   <span class="font11">corresponding </span>
   <span class="font11">depletion </span>
   <span class="font11">doi:./JVI.-. </span>
   <span class="font11">doi:./j.vaccine.... </span>
   <span class="font11">double; </span>
   <span class="font11">effector </span>
   <span class="font11">elicited </span>
   <span class="font11">euthanized </span>
   <span class="font11">i.c. </span>
   <span class="font11">inactivated </span>
   <span class="font11">incubated </span>
   <span class="font11">interferon </span>
   <span class="font11">model </span>
   <span class="font11">neurotropic </span>
   <span class="font11">outbreaks </span>
   <span class="font11">plaque </span>
   <span class="font11">prepared </span>
   <span class="font11">rank </span>
   <span class="font11">reporter </span>
   <span class="font11">respectively. </span>
   <span class="font11">response </span>
   <span class="font11">safety </span>
   <span class="font11">staining </span>
   <span class="font11">study </span>
   <span class="font11">supplemented </span>
   <span class="font11">target </span>
   <span class="font11">versus </span>
   <span class="font10">(log </span>
   <span class="font10">(n = ; </span>
   <span class="font10">**, </span>
   <span class="font10">/th </span>
   <span class="font10">A). </span>
   <span class="font10">CPE-based </span>
   <span class="font10">CTL </span>
   <span class="font10">Clin </span>
   <span class="font10">DENV- </span>
   <span class="font10">DNA </span>
   <span class="font10">Data </span>
   <span class="font10">IgG </span>
   <span class="font10">Infect </span>
   <span class="font10">JE-CVax, </span>
   <span class="font10">JEV, </span>
   <span class="font10">Likewise, </span>
   <span class="font10">NS, </span>
   <span class="font10">S). </span>
   <span class="font10">Sci </span>
   <span class="font10">added </span>
   <span class="font10">analysis. </span>
   <span class="font10">analyzed </span>
   <span class="font10">assess </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">brief, </span>
   <span class="font10">c-LAV </span>
   <span class="font10">containing </span>
   <span class="font10">control </span>
   <span class="font10">controls </span>
   <span class="font10">correlation </span>
   <span class="font10">cytokine </span>
   <span class="font10">cytotoxicity </span>
   <span class="font10">days </span>
   <span class="font10">derived </span>
   <span class="font10">detection </span>
   <span class="font10">developed </span>
   <span class="font10">diluted </span>
   <span class="font10">directed </span>
   <span class="font10">doi:./----. </span>
   <span class="font10">doi:./JVI...-.. </span>
   <span class="font10">efficacy </span>
   <span class="font10">encoding </span>
   <span class="font10">enzyme-linked </span>
   <span class="font10">experimental </span>
   <span class="font10">experiments </span>
   <span class="font10">expressing </span>
   <span class="font10">generated </span>
   <span class="font10">immunogenic </span>
   <span class="font10">including </span>
   <span class="font10">induced </span>
   <span class="font10">inoculated </span>
   <span class="font10">licensed </span>
   <span class="font10">memory </span>
   <span class="font10">method </span>
   <span class="font10">nonhuman </span>
   <span class="font10">normal </span>
   <span class="font10">number </span>
   <span class="font10">obtained </span>
   <span class="font10">overnight </span>
   <span class="font10">particular </span>
   <span class="font10">postvaccination </span>
   <span class="font10">protected </span>
   <span class="font10">protects </span>
   <span class="font10">provides </span>
   <span class="font10">represent </span>
   <span class="font10">sequence </span>
   <span class="font10">signal </span>
   <span class="font10">significance </span>
   <span class="font10">solid; </span>
   <span class="font10">stimulated </span>
   <span class="font10">strains </span>
   <span class="font10">strong </span>
   <span class="font10">structural </span>
   <span class="font10">studies </span>
   <span class="font10">study, </span>
   <span class="font10">virulent </span>
   <span class="font10">wild-type </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">(ADCC) </span>
   <span class="font10">(Mantel-Cox) </span>
   <span class="font10">(clone </span>
   <span class="font10">(i) </span>
   <span class="font10">(ii) </span>
   <span class="font10">(mean </span>
   <span class="font10">(–). </span>
   <span class="font10">****, </span>
   <span class="font10">-μm </span>
   <span class="font10">.SchlesingerJJ, </span>
   <span class="font10">ANOVA. </span>
   <span class="font10">Asia </span>
   <span class="font10">B). </span>
   <span class="font10">Belgium) </span>
   <span class="font10">CDa </span>
   <span class="font10">Dis:–. </span>
   <span class="font10">Europe </span>
   <span class="font10">Host </span>
   <span class="font10">Hum </span>
   <span class="font10">IFN </span>
   <span class="font10">Immunol:–. </span>
   <span class="font10">Ixiaro-vaccinated </span>
   <span class="font10">JE-CVax/Imojev </span>
   <span class="font10">MAb </span>
   <span class="font10">Negl </span>
   <span class="font10">P ≤ . </span>
   <span class="font10">RPMI </span>
   <span class="font10">SA---infected </span>
   <span class="font10">Scientific) </span>
   <span class="font10">Therefore, </span>
   <span class="font10">Trop </span>
   <span class="font10">Vaccine </span>
   <span class="font10">West </span>
   <span class="font10">YFV-D- </span>
   <span class="font10">YFV-D-based </span>
   <span class="font10">YFV-D-infected </span>
   <span class="font10">ZIKV-MR </span>
   <span class="font10">affinity </span>
   <span class="font10">animal </span>
   <span class="font10">antibodies. </span>
   <span class="font10">antigen. </span>
   <span class="font10">antigens </span>
   <span class="font10">blocking </span>
   <span class="font10">bold </span>
   <span class="font10">calculated </span>
   <span class="font10">cause </span>
   <span class="font10">cell-mediated </span>
   <span class="font10">conferred </span>
   <span class="font10">confirmed </span>
   <span class="font10">consists </span>
   <span class="font10">courier; </span>
   <span class="font10">cross-reactivity </span>
   <span class="font10">culture </span>
   <span class="font10">cultured </span>
   <span class="font10">demonstrate </span>
   <span class="font10">determine </span>
   <span class="font10">doi:./s---. </span>
   <span class="font10">effect </span>
   <span class="font10">em; </span>
   <span class="font10">endpoint </span>
   <span class="font10">established </span>
   <span class="font10">evidence </span>
   <span class="font10">experiments. </span>
   <span class="font10">expression </span>
   <span class="font10">gating </span>
   <span class="font10">goat </span>
   <span class="font10">harvested </span>
   <span class="font10">highly </span>
   <span class="font10">immunosorbent </span>
   <span class="font10">included </span>
   <span class="font10">indicated </span>
   <span class="font10">indirect </span>
   <span class="font10">induction </span>
   <span class="font10">infection, </span>
   <span class="font10">infection. </span>
   <span class="font10">long-lasting </span>
   <span class="font10">manufacturer’s </span>
   <span class="font10">mediate </span>
   <span class="font10">mediated </span>
   <span class="font10">monoclonal </span>
   <span class="font10">mortality </span>
   <span class="font10">nAbs. </span>
   <span class="font10">nonneutralizing </span>
   <span class="font10">onset </span>
   <span class="font10">plated </span>
   <span class="font10">presence </span>
   <span class="font10">primary </span>
   <span class="font10">proteins. </span>
   <span class="font10">pt;} </span>
   <span class="font10">raised </span>
   <span class="font10">respectively) </span>
   <span class="font10">resulting </span>
   <span class="font10">robust </span>
   <span class="font10">secondary </span>
   <span class="font10">seeding </span>
   <span class="font10">serial </span>
   <span class="font10">serum. </span>
   <span class="font10">served </span>
   <span class="font10">signaling </span>
   <span class="font10">solution </span>
   <span class="font10">specific </span>
   <span class="font10">statistical </span>
   <span class="font10">strategy </span>
   <span class="font10">susceptible </span>
   <span class="font10">testing </span>
   <span class="font10">tetravalent </span>
   <span class="font10">transfected </span>
   <span class="font10">transfection </span>
   <span class="font10">vaccine, </span>
   <span class="font10">values </span>
   <span class="font10">vigorous </span>
   <span class="font10">washes </span>
   <span class="font10"> mM </span>
  </p>
 </body>
</html>
